Bafna Pharmaceuticals Market Cap ($101.54M USD)
Bafna Pharmaceuticals Market Cap ($101.54M USD). As of June 8, 2026, Bafna Pharmaceuticals (BAFNAPH) market capitalisation is ₹913.84 Cr ($101.54M), with 4.71 Cr shares outstanding at a current price of ₹193.97 on NSE, ranking 1588 out of 5368 companies by market cap in our screener. Bafna Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Bafna Pharmaceuticals share price chart.
Market Cap History of Bafna Pharmaceuticals (Last 10 Years)
BAFNAPH market capitalisation from year-end NSE closing prices over the last 10 years. Examine Bafna Pharmaceuticals quarterly financials for recent quarterly revenue, profit and EPS trends.
End of Year Market Cap History — Bafna Pharmaceuticals
BAFNAPH year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with BAFNAPH stock valuation models to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹913.84 Cr
$101.54M USD
|
₹193.97 | NSE | +64.37% |
| 2025 |
₹555.97 Cr
$61.77M USD
|
₹118.01 | NSE | +49.57% |
| 2024 |
₹371.72 Cr
$41.30M USD
|
₹78.90 | NSE | -14.24% |
| 2023 |
₹433.43 Cr
$48.16M USD
|
₹92.00 | NSE | -8.68% |
| 2022 |
₹474.66 Cr
$52.74M USD
|
₹100.75 | NSE | -33.96% |
| 2021 |
₹718.70 Cr
$79.86M USD
|
₹152.55 | NSE | -10.71% |
| 2020 |
₹804.92 Cr
$89.44M USD
|
₹170.85 | NSE | - |